Timing of sodium-glucose cotransporter 2 inhibitor initiation and post-discharge outcomes in acute heart failure with diabetes: A population-based cohort study

被引:1
|
作者
Wu, Che-Yuan [1 ,2 ]
Shah, Baiju R. [3 ,4 ,5 ]
Sharma, Abhinav [6 ,7 ]
Sheng, Yiru [3 ]
Liu, Peter P. [8 ]
Kopp, Alexander [3 ]
Saskin, Refik [3 ]
Edwards, Jodi D. [8 ,9 ,10 ]
Swardfager, Walter [1 ,2 ,11 ]
机构
[1] Univ Toronto, Dept Pharmacol & Toxicol, 1 Kings Coll Circle, Toronto, ON M5S 1A8, Canada
[2] Sunnybrook Res Inst, Dr Sandra Black Ctr Brain Resilience & Recovery, Hurvitz Brain Sci Program, Toronto, ON, Canada
[3] ICES, Toronto, ON, Canada
[4] Sunnybrook Hlth Sci Ctr, Dept Med, Div Endocrinol, Toronto, ON, Canada
[5] Univ Toronto, Dept Med, Toronto, ON, Canada
[6] McGill Univ, Hlth Ctr, Div Cardiol, Montreal, PQ, Canada
[7] McGill Univ, Hlth Ctr, DREAM CV Lab, Montreal, PQ, Canada
[8] Univ Ottawa, Heart Inst, Ottawa, ON, Canada
[9] Univ Ottawa, Sch Epidemiol & Publ Hlth, Ottawa, ON, Canada
[10] ICES UOttawa, Ottawa, ON, Canada
[11] KITE Univ Hlth Network Toronto Rehabil Inst, Toronto, ON, Canada
基金
加拿大健康研究院;
关键词
Acute heart failure; Diabetes; SGLT2; inhibitor; Pharmacoepidemiology; IMPACT; RISK;
D O I
10.1002/ejhf.3464
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Sodium-glucose cotransporter 2 (SGLT2) inhibitors in acute heart failure. image
引用
收藏
页码:307 / 316
页数:10
相关论文
共 50 条
  • [1] Effectiveness of Early Versus Delayed post-Discharge Sodium-Glucose Cotransporter-2 Inhibitor Initiation in Acute Heart Failure with Type 2 Diabetes: A Population-Based Cohort Study
    Wu, Che-Yuan
    Shah, Baiju R.
    Sharma, Abhinav
    Sheng, Yiru
    Kopp, Alexander
    Saskin, Refik
    Edwards, Jodi D.
    Swardfager, Walter
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2024, 33 : 222 - 223
  • [2] Association of sodium-glucose cotransporter 2 inhibitors with post-discharge outcomes in patients with acute heart failure with type 2 diabetes: a cohort study
    Sohee Park
    Han Eol Jeong
    Hyesung Lee
    Seng Chan You
    Ju-Young Shin
    Cardiovascular Diabetology, 22
  • [3] Association of sodium-glucose cotransporter 2 inhibitors with post-discharge outcomes in patients with acute heart failure with type 2 diabetes: a cohort study
    Park, Sohee
    Jeong, Han Eol
    Lee, Hyesung
    You, Seng Chan
    Shin, Ju-Young
    CARDIOVASCULAR DIABETOLOGY, 2023, 22 (01)
  • [4] Short-term outcomes after sodium-glucose cotransporter-2 inhibitor initiation in a cohort of heart failure patients
    Martinez, Bryan O. Perez O.
    Adie, Sarah K.
    Marshall, Vincent D.
    Konerman, Matthew C.
    ESC HEART FAILURE, 2023, 10 (05): : 3223 - 3226
  • [5] Sodium-glucose cotransporter-2 inhibitors and clinical outcomes in patients with hypertrophic cardiomyopathy and diabetes: A population-based cohort study
    Jung, Mi-Hyang
    Cho, Jung Sun
    Lee, So-Young
    Youn, Jong-Chan
    Choi, Young
    Chung, Woo-Baek
    Lee, Jungkuk
    Kang, Dongwoo
    Kwon, Woojin
    Kim, Tae-Seok
    Ihm, Sang-Hyun
    Jung, Hae Ok
    EUROPEAN JOURNAL OF PREVENTIVE CARDIOLOGY, 2024,
  • [6] Sodium-glucose Cotransporter-2 Inhibitor Initiation, Risk of Recurrent Gout Flares, and Mortality in Patients with Gout and Type 2 Diabetes: A Population-based Cohort Study
    Wei, Jie
    Choi, Hyon K.
    Dalbeth, Nicola
    Li, Xiaoxiao
    Li, Changjun
    Zeng, Chao
    Lei, Guanghua
    Zhang, Yuqing
    ARTHRITIS & RHEUMATOLOGY, 2023, 75 : 488 - 490
  • [7] The use of sodium-glucose cotransporter 2 inhibitors and the incidence of uveitis in type 2 diabetes: a population-based cohort study
    Chung, Jui-Fu
    Yang, Po-Jen
    Chang, Chao-Kai
    Lee, Chia-Yi
    Huang, Jing-Yang
    Wang, Kai
    Yang, Shun-Fa
    ARCHIVES OF MEDICAL SCIENCE, 2024, 20 (02) : 402 - 409
  • [8] Cumulative sodium-glucose cotransporter 2 inhibitor exposure and incident dementia: A population-based cohort analysis
    Wu, Che-Yuan
    Iskander, Carina
    Wang, Christa
    Xiong, Lisa Y.
    Shah, Baiju R.
    Edwards, Jodi D.
    Kapral, Moira K.
    Herrmann, Nathan
    Lanctot, Krista L.
    Cogo-Moreira, Hugo
    MacIntosh, Bradley J.
    Rabin, Jennifer S.
    Black, Sandra E.
    Saskin, Refik
    Swardfager, Walter
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2023, 32 : 28 - 28
  • [9] Association of Sodium-Glucose Cotransporter 2 Inhibitors With Time to Dementia: A Population-Based Cohort Study
    Wu, Che-Yuan
    Iskander, Carina
    Wang, Christa
    Xiong, Lisa Y.
    Shah, Baiju R.
    Edwards, Jodi D.
    Kapral, Moira K.
    Herrmann, Nathan
    Lanctot, Krista L.
    Masellis, Mario
    Swartz, Richard H.
    Cogo-Moreira, Hugo
    MacIntosh, Bradley J.
    Rabin, Jennifer S.
    Black, Sandra E.
    Saskin, Refik
    Swardfager, Walter
    DIABETES CARE, 2023, 46 (02) : 297 - 304
  • [10] Sodium-glucose cotransporter 2 inhibitors and the risk of venous thromboembolism: A population-based cohort study
    Aloe, Stephanie
    Filliter, Christopher
    Salmasi, Shahrzad
    Igweokpala, Samuel
    Yu, Oriana H. Y.
    Tagalakis, Vicky
    Filion, Kristian B.
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2023, 89 (09) : 2902 - 2914